Clinical review report: Dexamethasone (Ozurdex) (Allergan, Inc.) indication for the treatment of adult patients with diabetic macular edema who are pseudophakic
Dexamethasone (Ozurdex) has a Health Canada-approved indication for the treatment of macular edema following central retinal vein occlusion, the treatment of noninfectious uveitis affecting the posterior segment of the eye, and for the treatment of adult patients with diabetic macular edema (DME) wh...
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2018, 2018 Nov
|
Series: | CADTH common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references